Evidence map›Paper›PMID 40170763›Full record

ArticleFungal systematics and evolution2025

Novel amplified fragment length polymorphism (AFLP) markers for typing medically relevant

R C Monteiro, C Z Yu, S Dolatabadi, F Hagen, M Sandoval-Denis, P W Crous, M C Fisher, S S Gonçalves, Z P de Camargo, A L Hofling-Lima and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Fungal systematics and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

R C MonteiroLaboratory of Emerging Fungal Pathogens, Department of Microbiology, Immunology, and Parasitology, Discipline of Cellular Biology, Federal University of São Paulo (UNIFESP), São Paulo 04023062, Brazil.
C Z YuLaboratory of Ophthalmology (LOFT), Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina (EPM), Federal University of São Paulo (UNIFESP), Sao Paulo 04023-062, Brazil.
S DolatabadiDepartment of Biology, Hakim Sabzevari University, Sabzevar, Iran.
F HagenWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
M Sandoval-DenisWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
P W CrousWesterdijk Fungal Biodiversity Institute, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
M C FisherMedical Research Council Center for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, UK.
S S GonçalvesInfectious Diseases Postgraduate Program, Center for Research in Medical Mycology, Federal University of Espírito Santo (UFES), Espírito Santo, 29043900, Brazil.
Z P de CamargoLaboratory of Emerging Fungal Pathogens, Department of Microbiology, Immunology, and Parasitology, Discipline of Cellular Biology, Federal University of São Paulo (UNIFESP), São Paulo 04023062, Brazil.
A L Hofling-LimaLaboratory of Ophthalmology (LOFT), Department of Ophthalmology and Visual Sciences, Escola Paulista de Medicina (EPM), Federal University of São Paulo (UNIFESP), Sao Paulo 04023-062, Brazil.
A M RodriguesLaboratory of Emerging Fungal Pathogens, Department of Microbiology, Immunology, and Parasitology, Discipline of Cellular Biology, Federal University of São Paulo (UNIFESP), São Paulo 04023062, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fusariosis is an emerging mycosis caused by diverse

Indexed as

AFLPBisifusariumepidemiologyfusariosisFusariumNeocosmospora

Identifiers

PMID40170763
PMCPMC11959234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.